Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 19 transactions totaling $15.8M, demonstrating a bullish sentiment with $15.8M in net insider flow. The most recent transaction on Mar 13, 2024 involved a transaction of 48 shares valued at $36.
CTXR Insider Activity Summary
Who Is Buying CTXR Stock?
No significant insider buying has been recorded for CTXR in the recent period.
Who Is Selling CTXR Stock?
No significant insider selling has been recorded for CTXR in the recent period.
Is Citius Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTXR is bullish with an Insider Alignment Score of 100/100 and a net flow of $15.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CTXR Frequently Asked Questions
Understanding CTXR Insider Activity
Insider trading at Citius Pharmaceuticals, Inc. (CTXR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading CTXR stock, having executed 19 transactions in the past 90 days. The most active insider is Leonard L. Mazur (Executive), who has made 10 transactions totaling $18.9M.
Related Tools
Track Citius Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CTXR file new Form 4 transactions